Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study

OBJECTIVES: To evaluate the effectiveness of the mRNA-1273 vaccine against SARS-CoV-2 variants and assess its effectiveness against the delta variant by time since vaccination. DESIGN: Test negative case-control study. SETTING: Kaiser Permanente Southern California (KPSC), an integrated healthcare s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruxvoort, Katia J, Sy, Lina S, Qian, Lei, Ackerson, Bradley K, Luo, Yi, Lee, Gina S, Tian, Yun, Florea, Ana, Aragones, Michael, Tubert, Julia E, Takhar, Harpreet S, Ku, Jennifer H, Paila, Yamuna D, Talarico, Carla A, Tseng, Hung Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671836/
https://www.ncbi.nlm.nih.gov/pubmed/34911691
http://dx.doi.org/10.1136/bmj-2021-068848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671836/
https://www.ncbi.nlm.nih.gov/pubmed/34911691
http://dx.doi.org/10.1136/bmj-2021-068848

Ejemplares similares